Cannabis science provides documentation of the doctor, confirms the successful treatment of skin cancer

Current article ratings:
Patients / public:5 (2 votes)healthcare Prof:3.5 (4 votes)
Cannabis science, Inc. (OTCBB: CBIS), U.S. biotech company developing pharmaceutical cannabis products. 9 March 2011 known cannabis science, that we to our press release with medical documentation of the effectiveness of our cannabis extracts for the treatment of photographically documented of skin cancer, as in our previous press release of 22 February follow would 2011. We are happy to announce that we have the physician documentation which confirms the successful treatment of basal cell carcinoma, which resulted from the application of a topical cannabis extract.

Currently is an enormous amount of controversy on the effects, the cannabinoids to cancer. Endocannabinoids, Phytocannabinoids and synthetic cannabinoids demonstrated cancer killing and Anti-metastatic properties in tissue culture and in animal models. At the formal right, approved FDA from clinical studies that prove or refute the therapeutic potential of cannabis extracts for the treatment of cancer would; Studies have not been conducted. Nevertheless, have accumulated a significant number of anecdotal observations that suggest people with different cancers seem to be cured by use of so-called "Rick Simpson's hemp oil".

There is widespread ignorance of the endocannabinoid system by medical professionals and lay people alike. The first evidence that an endocannabinoid system was resulted from an experiment in 1988 published. Due to the political and social endemic bias against medical cannabis, nourished by decades misinformation cannabis a path that we have successfully completed the largest probability of approval process FDA chose science. Our first test product are only current and will reduce all internal consumption and thus reduce possible abuse be formulated. Keep with these considerations in mind we first seek FDA approval for topically applied cannabis extracts for the treatment of basal cell carcinoma, a common form of skin cancer.

According to the National Cancer Institute the most common cancer in the United States is basal cell carcinoma. Given the terrible impact in general worldwide has cancer on so many people, cannabis science has decided to make his first goal for clinical study basal cell carcinoma.

Source:
Cannabis science, Inc.